Attached files
file | filename |
---|---|
EX-32.1 - EXHIBIT 32.1 - 9 METERS BIOPHARMA, INC. | v462702_ex32-1.htm |
EX-31.2 - EXHIBIT 31.2 - 9 METERS BIOPHARMA, INC. | v462702_ex31-2.htm |
EX-31.1 - EXHIBIT 31.1 - 9 METERS BIOPHARMA, INC. | v462702_ex31-1.htm |
EX-10.23 - EXHIBIT 10.23 - 9 METERS BIOPHARMA, INC. | v462702_ex10-23.htm |
10-K - 10-K - 9 METERS BIOPHARMA, INC. | v462702_10k.htm |
Exhibit 23.1
Consent of Independent Registered
Public Accounting Firm
We consent to the incorporation by reference in the registration statement on Form S-8 (File Nos. 333-215406) filed by Monster Digital, Inc. of our report, which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern, dated March 30, 2017, on our audits of the consolidated financial statements of Monster Digital, Inc. and Subsidiary as of December 31, 2016 and 2015 and for the years then ended, included in this Annual Report on Form 10-K of Monster Digital, Inc. for the year ended December 31, 2016.
/s/ CohnReznick LLP | |
Roseland, New Jersey | |
March 30, 2017 |